Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oligomeric Alpha-synuclein Levels as a Biomarker for Multiple System Atrophy

NCT01485549 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT01485549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01485549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oligomeric Alpha-synuclein Levels as a Biomarker for Multiple System Atrophy
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
November 26, 2012
Completion date
November 21, 2018
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy (msa)